Login
$TCRX
$0.19 +$0.00 (1.21%) Close

Insider Transactions

What TScan Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 3
Sells 0 0
Total trades 2 5

Shares traded

3 months 12 months
Acquired 0 81,732
Disposed 0 0
Net activity +0 +81,732

Common stock only — 3 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Zdraveski Zoran See Remarks Oct 01 Grant / award · A +300,000 — — 304,716
MacBeath Gavin Chief Executive Officer Oct 01 Grant / award · A +1,000,000 — — 1,049,767
Lynx1 Capital Management Lp 10% owner Dec 23 Open-market buy · P +6,232 $0.90 +$5.6K 8,019,148
Lynx1 Capital Management Lp 10% owner Dec 22 Open-market buy · P +75,500 $0.90 +$68K 8,012,916
Lynx1 Capital Management Lp 10% owner Dec 19 Open-market buy · P +80,069 $0.90 +$72K 7,937,416
Lynx1 Capital Management Lp 10% owner May 20 Open-market buy · P +1,200,000 $1.20 +$1.44M 7,946,141
Lynx1 Capital Management Lp 10% owner May 19 Open-market buy · P +1,388,794 $1.20 +$1.67M 6,746,141
Lynx1 Capital Management Lp 10% owner Dec 13 Open-market buy · P +100,000 $2.90 +$290K 5,357,347
Lynx1 Capital Management Lp 10% owner Dec 12 Open-market buy · P +31,800 $3.01 +$95.6K 5,257,347
Lynx1 Capital Management Lp 10% owner Nov 15 Open-market buy · P +947 $4.34 +$4.11K 5,225,547
Klencke Barbara Director Sep 23 Open-market buy · P +5,000 $5.29 +$26.5K 45,000
Klencke Barbara Director Aug 26 Open-market buy · P +5,000 $5.53 +$27.7K 40,000
Klencke Barbara Director Aug 23 Open-market buy · P +5,000 $5.69 +$28.5K 35,000
Zdraveski Zoran See Remarks Aug 23 Exercise / conversion · M +64,166 $2.49 +$160K 169,402
Zdraveski Zoran See Remarks Aug 23 Exercise / conversion · M +13,125 $1.81 +$23.8K 105,236
Zdraveski Zoran See Remarks Aug 23 Exercise / conversion · M +25,000 $3.27 +$81.8K 92,111
Zdraveski Zoran See Remarks Aug 23 Exercise / conversion · M +54,895 $4.85 +$266K 67,111
Zdraveski Zoran See Remarks Aug 23 Open-market sale · S −164,686 $5.78 −$952K 4,716
Barberich Timothy J Director Dec 19 Open-market buy · P +317 $4.97 +$1.58K 67,027
Barberich Timothy J Director Dec 18 Open-market buy · P +28,830 $4.89 +$141K 66,710

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support